National Healthcare Properties
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 year.
- Recent price momentum is -13.2% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 3.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 7.2x | Better than 92% |
| Price / Sales | 3.0x | Better than 41% |
Growth D-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 0.6% | Better than 30% |
| Free cash flow CAGR (3Y) | -78.6% | Better than 0% |
Profitability C-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 36.0% | Better than 42% |
| Operating margin | 6.1% | Better than 38% |
| Net margin | -20.8% | Better than 12% |
| Return on equity | -11.1% | Better than 19% |
| Return on invested capital | -1.5% | Better than 26% |
Momentum B
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -12.6% | Better than 44% |
| 6-month return | 1.1% | Better than 58% |
| Distance below 52-week high | 14.7% | Better than 72% |
Financial Health F
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 0.2x | Better than 1% |
| Debt to assets | 61.1% | Better than 8% |
| Interest coverage | 0.1x | Better than 25% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 60.0% | Better than 36% |
| Upside to average target | 23.1% | Better than 38% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 14.51
- Open
- 14.51
- Day range
- 14.47 - 14.97
- Avg price
- 14.83
- Volume
- 1.47M
- Turnover
- 21.84M
- Turnover ratei
- 2.03%
- Volume ratioi
- 1.27
- Amplitudei
- 3.45%
- 52-week rangei
- 11.14 - 17.37
Valuation
- P/Ei
- -14.13
- P/E (TTM)i
- -45.18
- P/Bi
- 1.18
- EPSi
- -1.05
- Book value / shi
- 12.58
- Net profit
- -76.54M
- Net assets
- 918.16M
Share structure
- Market cap
- 1.08B
- Float capi
- 1.08B
- Shares out
- 72.96M
- Float sharesi
- 72.76M
Dividend & listing
- Div yield (TTM)i
- 0.51%
- Dividend (TTM)
- 0.08
- Listing date
- 2026-04-22
14.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+5.22M net over the window
Short interest
- Shares short
- 2.79M
- % of floati
- 3.82%
- Days to coveri
- 1.62
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of National Healthcare Properties (NHP)?
National Healthcare Properties last traded at 14.82. This page shows a periodic quote snapshot. Check the displayed quote time.
What is National Healthcare Properties's market cap?
About 1.08B.
What is the P/E ratio of National Healthcare Properties?
The trailing twelve-month P/E is -45.18. The Valuation tab shows it against the stock's own five-year range.
Does National Healthcare Properties pay a dividend?
Yes. The trailing dividend yield is 0.51%. See the Dividends tab for the full payment history.
Is National Healthcare Properties a buy according to analysts?
The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 18.25, which implies 23.1% upside from the current price. This is not investment advice.
What is National Healthcare Properties's StockVane Quant Rating?
The StockVane Momentum strategy currently rates National Healthcare Properties a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.
National Healthcare Properties discussion 0 comments